peripheral neuropathy - HEALTHY
SP16 is an investigational intravenous therapy designed to treat chemotherapy-induced pain and peripheral neuropathy, also referred to as CIPPN. The treatment works through two proposed mechanisms: ... Yahoo Finance: Bold Therapeutics' Clinical-Stage Anticancer Agent BOLD-100 Demonstrates Protective Effects Against Chemotherapy-Induced Peripheral Neuropathy Bold Therapeutics' Clinical-Stage Anticancer Agent BOLD-100 Demonstrates Protective Effects Against Chemotherapy-Induced Peripheral Neuropathy The Columbus Dispatch: Serpin Pharma Receives FDA Clearance of IND Application for SP16 for Chemotherapy-Induced Peripheral Neuropathy Serpin Pharma receives FDA IND approval for SP16, a novel therapy for chemotherapy-induced peripheral neuropathy.
Context Explanation
Phase ... Serpin Pharma Receives FDA Clearance of IND Application for SP16 for Chemotherapy-Induced Peripheral Neuropathy Mayo Clinic's Translational Neuromuscular Disease Research Lab led by Nathan P. Staff, M.D., Ph.D., studies the biological mechanisms that cause peripheral neuropathy. Please provide your email address to receive an email when new articles are posted on .
Image Collection
Insight Material
Vitamin D insufficiency before chemotherapy associated with higher risk for peripheral neuropathy. Vitamin D ... Experts and P&G Health launch APAC’s first guidelines for pharmacists to screen, assess, and manage peripheral neuropathy using the MEDIC mnemonic. Past studies have suggested an association between vitamin D insufficiency and paclitaxel-induced peripheral neuropathy, a largely untreatable and sometimes permanent side effect of chemotherapy. To ...